TransEnterix Inc., which markets the Senhance Surgical Robotic System, appointed Shameze Rampertab as its new chief financial officer, effective 24 August, the company announced on 13 August.
Rampertab has more than 20 years of experience in the health care sector and most recently served as interim CEO at Zomedica Pharmaceuticals Corp., an animal health company.